Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.76143 | 81 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.55272 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.02574 | 83 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.68494 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.26422 | 84 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.14955 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.34194 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.6801 | 80 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.70999 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.4201 | 78 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.98028 | 75 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.22411 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.66159 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.28466 | 77 |